These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30376114)

  • 1. Hypermethylator Phenotype and Ectopic GIP Receptor in GNAS Mutation-Negative Somatotropinomas.
    Hage M; Chaligné R; Viengchareun S; Villa C; Salenave S; Bouligand J; Letouzé E; Tosca L; Rouquette A; Tachdjian G; Parker F; Lombès M; Lacroix A; Gaillard S; Chanson P; Kamenický P
    J Clin Endocrinol Metab; 2019 May; 104(5):1777-1787. PubMed ID: 30376114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The glucose-dependent insulinotropic polypeptide receptor is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives growth hormone (GH)-promoter activity in GH3 cells.
    Occhi G; Losa M; Albiger N; Trivellin G; Regazzo D; Scanarini M; Monteserin-Garcia JL; Fröhlich B; Ferasin S; Terreni MR; Fassina A; Vitiello L; Stalla G; Mantero F; Scaroni C
    J Neuroendocrinol; 2011 Jul; 23(7):641-9. PubMed ID: 21554434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GIP/GIPR axis is functionally linked to GH-secretion increase in a significant proportion of
    Regazzo D; Losa M; Albiger NM; Terreni MR; Vazza G; Ceccato F; Emanuelli E; Denaro L; Scaroni C; Occhi G
    Eur J Endocrinol; 2017 May; 176(5):543-553. PubMed ID: 28179449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KDM1A genotyping and expression in 146 sporadic somatotroph pituitary adenomas.
    Chasseloup F; Regazzo D; Tosca L; Proust A; Kuhn E; Hage M; Jublanc C; Mokhtari K; Dalle Nogare M; Avallone S; Ceccato F; Tachdjian G; Salenave S; Young J; Gaillard S; Parker F; Boch AL; Chanson P; Bouligand J; Occhi G; Kamenický P
    Eur J Endocrinol; 2024 Feb; 190(2):173-181. PubMed ID: 38330165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes.
    Regazzo D; Barbot M; Scaroni C; Albiger N; Occhi G
    Rev Endocr Metab Disord; 2020 Mar; 21(1):165-183. PubMed ID: 31933128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Methylation Analysis of the
    Dalle Nogare M; D'Annunzio S; Vazza G; Regazzo D; Picello L; Denaro L; Voltan G; Scaroni C; Ceccato F; Occhi G
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL3-mediated RNA m6A Hypermethylation Promotes Tumorigenesis and GH Secretion of Pituitary Somatotroph Adenomas.
    Chang M; Wang Z; Gao J; Yang C; Feng M; Niu Y; Tong WM; Bao X; Wang R
    J Clin Endocrinol Metab; 2022 Jan; 107(1):136-149. PubMed ID: 34491359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MANAGEMENT OF ENDOCRINE DISEASE: Etiology and outcome of acromegaly in patients with a paradoxical GH response to glucose.
    Hage M; Janot C; Salenave S; Chanson P; Kamenický P
    Eur J Endocrinol; 2021 May; 184(6):R261-R268. PubMed ID: 33830942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic Alterations and Complex Subclonal Architecture in Sporadic GH-Secreting Pituitary Adenomas.
    Hage M; Viengchareun S; Brunet E; Villa C; Pineau D; Bouligand J; Teglas JP; Adam C; Parker F; Lombès M; Tachdjian G; Gaillard S; Chanson P; Tosca L; Kamenický P
    J Clin Endocrinol Metab; 2018 May; 103(5):1929-1939. PubMed ID: 29474559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic GNAS mutation causes widespread and diffuse pituitary disease in acromegalic patients with McCune-Albright syndrome.
    Vortmeyer AO; Gläsker S; Mehta GU; Abu-Asab MS; Smith JH; Zhuang Z; Collins MT; Oldfield EH
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2404-13. PubMed ID: 22564667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GIP receptor antagonism eliminates paradoxical growth hormone secretion in some patients with acromegaly.
    Jensen MH; Gasbjerg LS; Skov-Jeppesen K; Jacobsen JCB; Poulsen SS; Zhou C; Jakubauskaite R; Poulsen FR; Bonde C; Albarazi M; Halle B; Christiansen CB; Sanni SJ; Byberg S; Hoe B; Holst JJ; Dela F; Rasmussen AK; Knop FK; Arlien-Søborg MC; Melmed S; Jørgensen JOL; Andersen MS; Hartmann B; Klose MC; Feldt-Rasmussen U; Sparre-Ulrich AH; Rosenkilde MM
    J Clin Endocrinol Metab; 2024 Aug; ():. PubMed ID: 39172542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-Genome Sequencing of Growth Hormone (GH)-Secreting Pituitary Adenomas.
    Välimäki N; Demir H; Pitkänen E; Kaasinen E; Karppinen A; Kivipelto L; Schalin-Jäntti C; Aaltonen LA; Karhu A
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3918-27. PubMed ID: 26280510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing's syndrome.
    Lecoq AL; Stratakis CA; Viengchareun S; Chaligné R; Tosca L; Deméocq V; Hage M; Berthon A; Faucz FR; Hanna P; Boyer HG; Servant N; Salenave S; Tachdjian G; Adam C; Benhamo V; Clauser E; Guiochon-Mantel A; Young J; Lombès M; Bourdeau I; Maiter D; Tabarin A; Bertherat J; Lefebvre H; de Herder W; Louiset E; Lacroix A; Chanson P; Bouligand J; Kamenický P
    JCI Insight; 2017 Sep; 2(18):. PubMed ID: 28931750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas.
    Ronchi CL; Peverelli E; Herterich S; Weigand I; Mantovani G; Schwarzmayr T; Sbiera S; Allolio B; Honegger J; Appenzeller S; Lania AG; Reincke M; Calebiro D; Spada A; Buchfelder M; Flitsch J; Strom TM; Fassnacht M
    Eur J Endocrinol; 2016 Mar; 174(3):363-72. PubMed ID: 26701869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of GNAS mutations in 60 growth hormone secreting pituitary tumors: correlation with clinical and pathological characteristics and surgical outcome based on highly sensitive GH and IGF-I criteria for remission.
    Freda PU; Chung WK; Matsuoka N; Walsh JE; Kanibir MN; Kleinman G; Wang Y; Bruce JN; Post KD
    Pituitary; 2007; 10(3):275-82. PubMed ID: 17594522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and clinical characteristics of Japanese patients with sporadic somatotropinoma.
    Matsumoto R; Izawa M; Fukuoka H; Iguchi G; Odake Y; Yoshida K; Bando H; Suda K; Nishizawa H; Takahashi M; Inoshita N; Yamada S; Ogawa W; Takahashi Y
    Endocr J; 2016 Nov; 63(11):953-963. PubMed ID: 27498687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of GNAS Mutations with Surgical Outcomes in Patients with Growth Hormone-Secreting Pituitary Adenoma.
    Jung H; Kim K; Kim D; Moon JH; Kim EH; Kim SH; Ku CR; Lee EJ
    Endocrinol Metab (Seoul); 2021 Apr; 36(2):342-350. PubMed ID: 33752302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and Epigenetic Characterization of Growth Hormone-Secreting Pituitary Tumors.
    Välimäki N; Schalin-Jäntti C; Karppinen A; Paetau A; Kivipelto L; Aaltonen LA; Karhu A
    Mol Cancer Res; 2019 Dec; 17(12):2432-2443. PubMed ID: 31578227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel somatic variants involved in biochemical activity of pure growth hormone-secreting pituitary adenoma without GNAS variant.
    Ku CR; Lim H; Lee YJ; Kim SH; Kim D; Kim SH; Lee MK; Bang D; Lee EJ
    Sci Rep; 2021 Aug; 11(1):16530. PubMed ID: 34400688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GH/PRL-secreting pituitary macroadenoma associated with GNAS p.Gln227Leu mutation: pediatric case report and review.
    Watanabe D; Yagasaki H; Kojika S; Ogiwara M; Kinouchi H; Nakane T; Inukai T
    Endocr J; 2019 May; 66(5):403-408. PubMed ID: 30814395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.